Aegis against Stroke and Dementia by Angiotensin Type 1 Receptor Blockers: New Beneficial Aspects

Qiu C, Winblad B, Fratiglioni L : The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005; 4 : 487–499. Article PubMed Google Scholar Wright JW, Reichert JR, Davis CJ, Harding JW : Neural plasticity and the brain renin-angiotensin system. Neurosci Biobehav Rev 2002; 26 : 529–552. Article CAS PubMed Google Scholar Takeda S, Sato N, Ogihara T, Morishita R : The renin-angiotensin system, hypertension and cognitive dysfunction in Alzheimer's disease: new therapeutic potential. Front Biosci 2008; 13 : 2253–2265. Article CAS PubMed Google Scholar Gard PR, Rusted JM : Angiotensin and Alzheimer's disease: therapeutic prospects. Expert Rev Neurother 2004; 4 : 87–96. Article CAS PubMed Google Scholar Gasparo MD, Catt KJ, Inagami T, Wright JW, Unger TH : International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharm Rev 2000; 52 : 415–472. PubMed Google Scholar Viswanathan M, Tsutsumi K, Correa FJ, Saavedra JM : Changes in expression of angiotensin receptor subtypes in the rat aorta during development. Biochem Biophys Res Commun 1991; 179 : 1361–1367. Article CAS PubMed Google Scholar Näveri L : The role of angiotensin receptor subtypes in cerebrovascular regulation in the rat. Acta Physiol Scand 1995; 155 : 2–48. Google Scholar Strömberg C, Näveri L, Saavedra JM : Nonpeptide angiotensin AT1 and AT2 receptor ligands modulate the upper limit of cerebral blood flow autoregulation in rats. J Cereb Blood Flow Metab 1993; 13 : 298–303. Article PubMed Google Scholar Phillips MI : Functions of angiotensin in the central nervous system. Annu Rev Physiol 1987; 49 : 413–435. Article CAS PubMed Google Scholar Landas S, Phillips MI, Stamler JF, Raizada MK : Visualization of specific angiotensin II binding sites in the brain by fluorescent microscopy. Science 1980; 210 : 791–793. Article CAS PubMed Google Scholar Van Houten M, Schiffrin EL, Mann JF, Posner BJ, Boucher R : Radioautographic localization of specific binding sites for bloodborne angiotensin II in the rat brain. Brain Res 1980; 186 : 480–485. Article CAS PubMed Google Scholar Iwai M, Inaba S, Tomono Y, et al : Attenuation of focal brain ischemia by telmisartan, an angiotensin type 1 receptor blocker, in atherosclerotic apolipoprotein E−deficient mice. Hypertens Res 2008; 31 : 161–168. Article CAS PubMed Google Scholar Dahlöf B, Devereux RB, Kjeldsen SE, et al , LIFE Study Group : Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359 : 995–1003. Article PubMed Google Scholar Schrader J, Lüders S, Kulschewski A, et al , Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group : The ACCESS Study: evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors. Stroke 2003; 34 : 1699–1703. Article PubMed Google Scholar Mochizuki S, Dahlöf B, Shimizu M, et al , Jikei Heart Study Group : Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet 2007; 369 : 1431–1439. Article CAS PubMed Google Scholar Armstrong DL, Garcia EA, Ma T, Quinones B, Wayner MJ : Angiotensin II blockade of long-term potentiation at the perforant path-granule cell synapse in vitro . Peptides 1996; 17 : 689–693. Article CAS PubMed Google Scholar Denny JB, Polan-Curtain J, Wayner MJ, Armstrong DL : Angiotensin II blocks hippocampal long-term potentiation. Brain Res 1991; 567 : 321–324. Article CAS PubMed Google Scholar Wayner MJ, Armstrong DL, Polan-Curtain JL, Denny JB : Ethanol and diazepam inhibition of hippocampal LTP is mediated by angiotensin II and AT1 receptors. Peptides 1993; 14 : 441–444. Article CAS PubMed Google Scholar Wayner MJ, Armstrong DL, Polan-Curtain JL, Denny JB : Role of angiotensin II and AT1 receptors in hippocampal LTP. Pharmacol Biochem Behav 1993; 45 : 455–464. Article CAS PubMed Google Scholar Wayner MJ, Polan-Curtain JL, Armstrong DL : Dose and time dependency of angiotensin II inhibition of hippocampal long-term potentiation. Peptides 1995; 16 : 1079–1082. Article CAS PubMed Google Scholar Morgan TM, Routtenberg A : Angiotensin injected into the neostriatum after learning disrupts retention performance. Science 1977; 196 : 87–89. Article CAS PubMed Google Scholar Lee EH, Ma YL, Wayner MJ, Armstrong DL : Impaired retention by angiotensin II mediated by the AT1 receptor. Peptides 1995; 16 : 1069. Article CAS PubMed Google Scholar DeNoble VJ, DeNoble KF, Spencer KR, et al : Non-peptide angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor: effect on a renin-induced deficit of a passive avoidance response in rats. Brain Res 1991; 61 : 5230–5235. Google Scholar Vermeer SE, Prins ND, den Heijer T, et al : Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348 : 1215–1222. Article PubMed Google Scholar Stewart R : Cardiovascular factors in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1998; 65 : 143–147. Article CAS PubMed PubMed Central Google Scholar Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD : Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 1999; 354 : 919–920. Article CAS PubMed Google Scholar de la Torre JC : Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004; 3 : 184–190. Article PubMed Google Scholar PROGRESS Collaborative Group : Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 2003; 163 : 1069–1075. Lithell H, Hansson L, Skoog I, SCOPE Study Group : The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization. J Hypertens 2004; 8 : 1605–1612. Article Google Scholar Trenkwalder P : The Study on COgnition and Prognosis in the Elderly (SCOPE)—recent analyses. J Hypertens Suppl 2006; 24 : S107–S114. Article CAS PubMed Google Scholar Benson SC, Pershadsingh HA, Ho CI, et al : Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity. Hypertension 2004; 43 : 993–1002. Article CAS PubMed Google Scholar Kurtz TW : Treating the metabolic syndrome: telmisartan as a peroxisome proliferator−activated receptor-gamma activator. Acta Diabetol 2005; 42 ( Suppl 1): S9–S16. Article CAS PubMed Google Scholar Luo Y, Yin W, Signore AP, et al : Neuroprotection against focal ischemic brain injury by the peroxisome proliferator−activated receptor-gamma agonist rosiglitazone. J Neurochem 2006; 97 : 435–448. Article CAS PubMed Google Scholar Download references